Johnson & Johnson Innovative Medicine Belgium, formerly Janssen, develops science-based medicines and therapies across oncology, immunology, neuroscience, cardiopulmonary and pulmonary hypertension, and provides Belgium/Luxembourg public contact routes for medical information, product-quality complaints, adverse-event reporting, product ordering, availability, clinical-trial information, collaborations and patient engagement.